DLA Piper has advised ResApp Health Limited on the deal. ResApp Health Limited (ResApp) announced its A$180 million cash acquisition by Pfizer Australia Holdings Pty Limited…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
